Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cheryl Scott Insider Profile
4 Followers
Cheryl Scott, Director at Evolent Health, holds 10.10K shares in Progyny (Ticker: PGNY), holds 51.50K shares in Evolent Health (Ticker: EVH). Most recently, Cheryl Scott Sold ― shares of Progyny on Jul 01, 2024 for an estimated value of 41.51K.
Profitable Transactions
8 out of 8 Profitable Transactions
Average Return
+32.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
The most profitable trade made by Cheryl Scott
Cheryl Scott's Trading History
Evolent Health
Jun 10, 2024
Director
Uninformative Buy
―
$582.43K
Progyny
Jul 01, 2024
Director
Informative Sell
41.51K
$141.17K
List of latest transactions for each holding click on a transaction to see Cheryl Scott's performance on stock
You May Also Like
Cheryl Scott insider profile FAQ
What is the percentage of profitable transactions made by Cheryl Scott?
The percentage of profitable transactions made by Cheryl Scott is 100%.
What is the average return per transaction made by Cheryl Scott?
The average return per transaction made by Cheryl Scott is 32.50%.
What stocks does Cheryl Scott hold?
Cheryl Scott holds: EVH, PGNY stocks.
What was Cheryl Scott’s latest transaction?
Cheryl Scott latest transaction was an Informative Sell of $41.51K.
What was Cheryl Scott's most profitable transaction?
Cheryl Scott’s most profitable transaction was an Informative Sell of EVH stock on June 12, 2018. The return on the trade was 65.80%.
What is Cheryl Scott's role in Evolent Health?
Cheryl Scott's role in Evolent Health is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.